Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May 10;7(9):177-88.
doi: 10.4239/wjd.v7.i9.177.

Positive evidence for vitamin A role in prevention of type 1 diabetes

Affiliations
Review

Positive evidence for vitamin A role in prevention of type 1 diabetes

Somaye Yosaee et al. World J Diabetes. .

Abstract

Type 1 diabetes mellitus (T1DM) as one of the most well-known autoimmune disease, results from the destruction of β-cells in pancreas by autoimmune process. T1DM is fatal without insulin treatment. The expansion of alternative treatment to insulin is a dream to be fulfilled. Currently autoimmunity is considered as main factor in development of T1DM. So manipulation of the immune system can be considered as alternative treatment to insulin. For the past decades, vitamin A has been implicated as an essential dietary micronutrient in regulator of immune function. Despite major advantage in the knowledge of vitamin A biology, patients who present T1DM are at risk for deficiency in vitamin A and carotenoids. Applying such evidences, vitamin A treatment may be the key approach in preventing T1DM.

Keywords: Autoimmune; Diabetes; Insulin; Pancreas; Vitamin A.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic diagram for the pathways of vitamin A effects on innate immune system. NK: Natural killer; TNF: Tumor necrosis factors; IL: Interleukin; MoDCs: Monocyte-derived dendritic cells.
Figure 2
Figure 2
Immunology of type 1 diabetes[115]. TNF: Tumor necrosis factors; IL: Interleukin; MoDCs: Monocyte-derived dendritic cells; APCs: Antigen presenting cells; IFN: Interferon; HLA: Human leukocyte antigen.

Similar articles

Cited by

References

    1. Szablewski L. Role of immune system in type 1 diabetes mellitus pathogenesis. Int Immunopharmacol. 2014;22:182–191. - PubMed
    1. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221–229. - PubMed
    1. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet. 2009;373:2027–2033. - PubMed
    1. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AW, Hill RD, Bingley PJ, Patterson CC, et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med. 1999;16:466–471. - PubMed
    1. Federation ID. Idf diabetes atlas. Brussels: International Diabetes Federation; 2013.